Results 11 to 20 of about 23 (22)

Comparative bioavailability and steady state fluctuations of tegretol commercial and carbamazepine oros tablets in adult and pediatric epileptic patients

Biopharmaceutics and Drug Disposition, 1992
G M Kochak, R H Levy
exaly  

Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations

European Journal of Drug Metabolism and Pharmacokinetics, 1994
J M Cardot
exaly  

OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: A randomized, placebo-controlled cross-over study

European Neuropsychopharmacology, 2014
Denise Bijlenga, J J S Kooij, Aartjan Tf Beekman   +2 more
exaly  

Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone

Current Medical Research and Opinion, 2007
Jaime Caro, Rainer Sabatowski, Dominique Dubois   +2 more
exaly  

Parental Perceived Benefits of OROS-Methylphenidate Treatment for the Child with Attention-Deficit/Hyperactivity Disorder and for Parents Themselves

Pharmacopsychiatry, 2013
Jun Hwee Kim, Jung-Wook Kim
exaly  

Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD

European Neuropsychopharmacology, 2011
Ronna Fried, Joseph Biederman, Eric Mick   +2 more
exaly  

An Exploration of Site Effects in a Multisite Trial of OROS-Methylphenidate for Smokers with Attention Deficit/Hyperactivity Disorder

American Journal of Drug and Alcohol Abuse, 2011
Mei-Chen Hu, Carla A Green, T Winhusen
exaly  

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS® MPH

European Child and Adolescent Psychiatry, 2005
Paramala Santosh, Peter Hoare, Remschmidt H   +2 more
exaly  

Gastric emptying of OROS tablets in man

International Journal of Pharmaceutics, 1984
exaly  

The use of high doses of OROS hydromorphone in an acute palliative care unit

Current Medical Research and Opinion, 2011
Sebastiano Mercadante
exaly